loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X

What is Route Evaluation & Development? A CDMO that can optimize your API synthesis process early during technology transfer will reduce the risk of project delay or failure. That will also help your molecule run more efficiently in their plant. And time is money. Most medicinal chemists design novel active pharmaceutical ingredients (APIs) to secure a patent and IP protection, not to create a scalable production process. That makes sense. They are racing against the clock, running through fail

Filters Filter
Cross PopUp
FILTER :

filter

01 PMC Isochem (1)

02 EUROAPI (1)

03 Cayman Chemical Company Inc (1)

04 Aspen API (1)

05 M2i Group (1)

06 Prague Scientific (1)

07 Aesica Pharmaceuticals Limited (1)

08 Bellen Chemistry (1)

09 Bioindustria L.I.M. Spa (1)

10 Biolink LifeSciences (1)

11 CARBOGEN AMCIS AG (1)

12 CLEARSYNTH LABS LIMITED (1)

13 Cambrex Corporation (1)

14 Curia (1)

15 Eurofins CDMO (1)

16 Evotec (1)

17 Nanjing Dorra Pharmaceutical Technology Co.,Ltd (1)

18 POLYPHARMA TECH & SCIENCES (1)

19 Siegfried AG (1)

20 UQUIFA (1)

21 ZCL Chemicals Limited (1)

filter

01 China (2)

02 Czech Republic (1)

03 France (4)

04 Germany (2)

05 India (2)

06 Italy (1)

07 Netherlands (1)

08 Spain (1)

09 Switzerland (2)

10 U.S.A (4)

11 United Kingdom (1)

Close
4